Other News

‘Nobody Sees Us’: Testing-Lab Workers Strain Under Demand

Laboratory technologists have been working nonstop to help the nation diagnose an ever-growing number of coronavirus cases.. In March, April Abbott dragged a hospital bed into her office at Deaconess

WHO pre-qualifies COVID 19 Ag Tests

List of EUL products eligible for procurement: Instruction for Use (IFUs) Source: WHO

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

Abstract COVID-19, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), represents a global crisis. Key to SARS-CoV-2 therapeutic development is unraveling the mechanisms driving high infectivity, broad tissue tropism and severe

WHO Guidance on Use of Rapid Antigen Tests for SARS-CoV-2

Since the beginning of the COVID-19 pandemic, laboratories have been using nucleic acid amplification tests (NAATs), such as real time reverse transcription polymerase chain reaction (rRT-PCR) assays, to detect SARS-CoV-2,

COVID-19 pandemic exacerbates suicide risk factors

Washington, DC, September 10, 2020 (PAHO) – The Pan American Health Organization (PAHO) today warned that the COVID-19 pandemic may exacerbate suicide risk factors, urging people to speak about the

PAHO Director asks PROSUR leaders to participate in initiative to fast track access to COVID-19 vaccines

Washington, D.C., August 28, 2020 (PAHO) — The Director of the Pan American Health Organization (PAHO), Carissa F. Etienne, yesterday invited the PROSUR block of South American presidents to work

The Impact of COVID-19 on HIV Clinical Practice

SARS-COV-2 is an RNA virus from the coronavirus family, the causative agent of COVID-19. With nearly 6,000,000 cases worldwide, 365,000 deaths and detection in at least well over 200 countries,

WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls

Countries seek innovative ways to mitigate the impact of disruptions and keep services going. Seventy-three countries have warned that they are at risk of stock-outs of antiretroviral (ARV) medicines as